Skip to main content
Clinical Trials/CTRI/2024/05/067348
CTRI/2024/05/067348
Not yet recruiting
Phase 2

A Randomised controlled clinical study to evaluate the efficacy of local application of Tilkusumadi Lepa in the treatment of Vipadika Kushtha in children. - NI

Dr.Rushikesh Khandu Borase0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr.Rushikesh Khandu Borase
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Dr.Rushikesh Khandu Borase

Eligibility Criteria

Inclusion Criteria

  • 1\)Age group between 4 years to 14 years will be selected irrespective of gender,
  • socioeconomic status \& religion.
  • 2\)Patients presenting with Panipadasphutan (cracks on the feet /plantar region) and
  • with any of the following symptoms will be selected \-
  • 1\) Tivravedana (Severe pain)
  • 2\) Alpakandu (Mild itching)
  • 3\) Raga (Inflammation)

Exclusion Criteria

  • 1\)Patients below 4 years and above 14 years of age.
  • 2\)Patients having systemic disorders like Diabetes mellitus which interfere with the
  • course of treatment.
  • 3\)Known allergy to any of the control/ trial group
  • 4\)Patient suffering from other dermatological /systemic diseases.
  • 5\)Vipadika Kushtha with secondary infection.

Outcomes

Primary Outcomes

Not specified

Similar Trials